08/01/2008
Francesco Saia, MD, PhD; Angela Hoye, MB, MRCP, MD, MBChB; Pedro A. Lemos, MD; Patrick W. Serruys, MD, PhD; Chourmouzios A. Arampatzis, MD; Muzaffer Degertekin, MD; Sjoerd H. Hofma, MD; Eugene P. McFadden, MB, MD; Georgios Sianos, MD, PhD; Pieter C. Smits, MD, PhD; Kengo Tanabe, MD; Willem J. van der Giessen, MD, PhD; Pim J. de Feyter, MD, PhD; Ron T. van Domburg, PhD
ABSTRACT: The use of bare stents for the percutaneous intervention of saphenous vein bypass grafts (SVGs) is associated with a high subsequent rate of restenosis. To assess the impact of the sirolimus-eluting stent (SES), we studied 19...
ABSTRACT: The use of bare stents for the percutaneous intervention of saphenous vein bypass grafts (SVGs) is associated with a high subsequent rate of restenosis. To assess the impact of the sirolimus-eluting stent (SES), we studied 19...
ABSTRACT: The use of bare stents...